A novel splice site mutation of the thiazide-sensitive NaCl cotransporter gene in a Japanese patient with Gitelman syndrome.
Gitelman syndrome (GS, MIM 263800) is an inherited disorder characterized by metabolic alkalosis with hypokalemia, hypomagnesemia, and hypocalciuria. The genetic abnormalities causing GS are known to lie in the thiazide-sensitive NaCl cotransporter (TSC), which is expressed in the distal tubule of the kidney. The TSC gene, located at chromosome 16, consists of 26 exons and encodes the protein containing 12 putative transmembrane domains with long intracellular amino and carboxy termini. Most of the abnormalities identified in GS were missense mutations, distributed throughout the TSC gene without a hot spot. A 42-year-old Japanese man was introduced for close examination of hypokalemia. In renal clearance studies using furosemide or thiazide, chloride clearance was increased after furosemide but not after thiazide administration. Furthermore, the distal fractional chloride reabsorption was dramatically decreased by furosemide but not thiazide administration, suggesting a defect in the distal tubule. We then analyzed the TSC gene to confirm the diagnosis of GS, and identified a novel G to T mutation at the acceptor splice site preceding exon 14, resulting in disruption of a conventional 3'AG consensus splice site. Abnormal splicing by this mutation is predicted to cause the formation of truncated TSC with a partial deletion of the transmembrane domain, which will loose the function of transporter. In conclusion, we have identified a unique novel splice site mutation of the TSC gene in GS. The predicted structure of this mutant TSC can conceivably cause an impairment of the transporter activity and thereby be responsible for the development of GS in our patient.
Department of Clinical Molecular Medicine, Division of Endocrinology/Metabolism, Neurology and Hematology/Oncology, Kobe University Graduate School of Medicine, Kobe, Japan. iidak2@aol.com
K
K
Iida
M
M
Hanafusa
I
I
Maekawa
T
T
Kudo
K
K
Takahashi
S
S
Yoshioka
M
M
Kishimoto
G
G
Iguchi
T
T
Tsukamoto
Y
Y
Okimura
H
H
Kaji
K
K
Chihara
D000328:Adult; D001477:Bartter Syndrome / Q000235:genetics*; D001581:Benzothiadiazines; D004232:Diuretics; D006801:Humans; D007686:Kidney Tubules, Distal / Q000737:chemistry; D008297:Male; D020125:Mutation, Missense / Q000235:genetics*; D012150:Polymorphism, Restriction Fragment Length; D022821:RNA Splice Sites / Q000235:genetics*; D049993:Sodium Chloride Symporter Inhibitors / Q000494:pharmacology*; D028021:Sodium-Potassium-Chloride Symporters / Q000032:analysis / Q000187:drug effects* / Q000235:genetics*
D001581:Benzothiadiazines; D004232:Diuretics; D022821:RNA Splice Sites; D049993:Sodium Chloride Symporter Inhibitors; D028021:Sodium-Potassium-Chloride Symporters